Assessment of the Molecular Diagnostic Market for 38 NA Tests in
Italy, 2011
Published on May 2012

Report Summary
Update of the 2009 started comprehensive European market assessment for molecular diagnostics from the end user perspective.
Hospital and private laboratories have been surveyed to collect information on NA tests, test volumes, used platforms and
technologies (amplification & detection) and reagents. For data reliability and accurate projections at segment level a 3 step
methodology has been applied:
Step 1: Identification of the total number of laboratories
Step 2: Identification of the total number of laboratories using NA technologies (several units per hospital)
Step 3: Interviews with NA laboratories on NA test volume, kits, platforms and trends. A list of 38 NA tests has been provided to the
labs for structured data entry. The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR),
Real Time PCR (RT-PCR), TMA, LCR, NASBA, SDA, HCA, bDNA.
dii is an international market research company entirely specialised in healthcare markets providing market information and support to
strategic business decisions. In cooperation with key industry we have desigend the Continuous European Molecular Market
Assessment which has been realized in 2009 and 2011 with the 2 main objectives:
1) Assess the market for molecular diagnostics (# of labs using which technology, test volumes, platforms and reagents)
2) Understand long term trends and needs